A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Marijuana and its CD4 Receptors: A New HIV Treatment Strategy?
Pathway to a Cure: Cancer Drug Helps Purge HIV From Resting Cells
Life Expectancy With HIV Increases Dramatically
Undetectable Viral Load? Not Necessarily in Semen
Engineering CD8 Cells to Kill HIV in Tissues
Pathway to a Cure: Positive Results Continue for Sangamo's CCR5 Gene Therapy
Revised U.S. Guidelines: HIV Treatment is Recommended for All People Living With HIV
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailprint

October 1, 2007

Acetyl-L-Carnitine Promising for Neuropathy

In a recent article in the journal CNS Drugs, Michael Youle, MD, a noted HIV specialist at London’s Royal Free Hospital, claims that acetyl-L-carnitine (LAC), an over-the-counter amino acid supplement, is a promising treatment for a condition known as peripheral neuropathy. Characterized by alternating numbness, tingling and pain in the feet, legs, hands and arms, peripheral neuropathy is nerve damage that can result from the use of certain antiretroviral medications, predominantly Videx (didanosine) and Zerit (stavudine). There are currently few treatments for neuropathy, and none are highly effective.

In the article, Dr. Youle reviews several small studies that have explored whether taking LAC can protect people from developing neuropathy or treat people who have already developed it. One early study found that people who took LAC (1500 mg twice a day) showed evidence of both nerve regeneration and a reduction in painful symptoms. A somewhat larger study, published early this year, found that LAC was significantly better able than a placebo to alleviate neuropathy symptoms.

Many people with HIV have developed resistance to a number of antiretroviral medications and must use drugs like Videx and Zerit to build an effective antiretroviral regimen. Physicians need an effective method to prevent neuropathy from developing, if possible, and to treat it when prevention is not possible, writes Dr. Youle. He concludes that LAC shows promise in this regard and deserves larger studies to prove its effectiveness.


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    adoniz89
    san dimas
    California


    sequoiamv
    San Jose
    California


    sefarady
    Los Angeles
    California


    thebake
    Sioux Falls
    South Dakota
Click here to join POZ Personals!
Conference Coverage

19th Conference on Retroviruses and Opportunistic Infections (CROI 2012)
Seattle, Washington
March 5 - 8, 2012


6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.